Quanterix Stock Forecast, Price & News

3 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Quanterix in the last year. There are currently 3 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "buy" Quanterix stock.
View analyst ratings for Quanterix or view top-rated stocks.

Wall Street analysts have given Quanterix a "Buy" rating, but there may be better short-term opportunities in the market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new trading ideas, but Quanterix wasn't one of them. MarketBeat thinks these five stocks may be even better buys.
View MarketBeat's top stock picks here.

Quanterix saw a increase in short interest during the month of January. As of January 15th, there was short interest totaling 459,100 shares, an increase of 14.5% from the December 31st total of 400,900 shares. Based on an average trading volume of 300,500 shares, the short-interest ratio is currently 1.5 days. Approximately 2.0% of the company's stock are short sold.
View Quanterix's Short Interest.

Quanterix is scheduled to release its next quarterly earnings announcement on Tuesday, March 2nd 2021.
View our earnings forecast for Quanterix.

Quanterix will be holding an earnings conference call on Tuesday, March 2nd at 12:00 AM Eastern. Interested parties can register for or listen to the call using this link or dial in at Not Available.

Quanterix Co. (NASDAQ:QTRX) released its earnings results on Thursday, November, 5th. The company reported $0.07 EPS for the quarter, beating the Thomson Reuters' consensus estimate of ($0.43) by $0.50. The company had revenue of $31.39 million for the quarter, compared to analysts' expectations of $15 million. Quanterix had a negative trailing twelve-month return on equity of 22.37% and a negative net margin of 41.69%.
View Quanterix's earnings history.

Quanterix's stock was trading at $18.51 on March 11th, 2020 when COVID-19 (Coronavirus) reached pandemic status according to the World Health Organization (WHO). Since then, QTRX shares have increased by 325.1% and is now trading at $78.68.
View which stocks have been most impacted by COVID-19.

Quanterix updated its fourth quarter 2020 IntraDay earnings guidance on Wednesday, January, 13th. The company provided EPS guidance of for the period. The company issued revenue guidance of $20-22 million, compared to the consensus revenue estimate of $21.7 million.

3 equities research analysts have issued twelve-month target prices for Quanterix's stock. Their forecasts range from $40.00 to $75.00. On average, they anticipate Quanterix's share price to reach $58.33 in the next twelve months. This suggests that the stock has a possible downside of 25.9%.
View analysts' price targets for Quanterix or view top-rated stocks among Wall Street analysts.

15 employees have rated Quanterix CEO Kevin Hrusovsky on Glassdoor.com. Kevin Hrusovsky has an approval rating of 70% among Quanterix's employees.

Some companies that are related to Quanterix include Bruker (BRKR), Coherent (COHR), Pacific Biosciences of California (PACB), Berkeley Lights (BLI), Bionano Genomics (BNGO), Accelerate Diagnostics (AXDX), Fluidigm (FLDM), EyePoint Pharmaceuticals (EYPT), Harvard Bioscience (HBIO), Astrotech (ASTC), Precipio (PRPO), Scientific Industries (SCND), HTG Molecular Diagnostics (HTGM), BioForce Nanosciences (BFNH) and Pressure BioSciences (PBIO).
View all of QTRX's competitors.

Based on aggregate information from My MarketBeat watchlists, some companies that other Quanterix investors own include Editas Medicine (EDIT), Novavax (NVAX), Akoustis Technologies (AKTS), Advanced Micro Devices (AMD), CRISPR Therapeutics (CRSP), The Walt Disney (DIS), Illumina (ILMN), Sorrento Therapeutics (SRNE), Cisco Systems (CSCO) and Intellia Therapeutics (NTLA).

(QTRX) raised $50 million in an IPO on Thursday, December 7th 2017. The company issued 3,300,000 shares at a price of $14.00-$16.00 per share. J.P. Morga and Leerink Partners acted as the underwriters for the IPO and BTIG and Evercore ISI were co-managers.

Quanterix trades on the NASDAQ under the ticker symbol "QTRX."

Quanterix's stock is owned by a variety of retail and institutional investors. Top institutional investors include BlackRock Inc. (5.50%), Frontier Capital Management Co. LLC (4.74%), Price T Rowe Associates Inc. MD (3.58%), Ashford Capital Management Inc. (1.30%), Tikvah Management LLC (1.21%) and Monashee Investment Management LLC (1.26%). Company insiders that own Quanterix stock include Amol Chaubal, David C Duffy, David R Walt, Dawn Mattoon, E Kevin Hrusovsky, John J Fry, Marijn E Dekkers, Mark T Roskey and Martin D Madaus.
View institutional ownership trends for Quanterix.

QTRX stock was sold by a variety of institutional investors in the last quarter, including BlackRock Inc., Price T Rowe Associates Inc. MD, Nuveen Asset Management LLC, Next Century Growth Investors LLC, Royce & Associates LP, Assenagon Asset Management S.A., Northern Trust Corp, and Bank of New York Mellon Corp. Company insiders that have sold Quanterix company stock in the last year include Amol Chaubal, David C Duffy, Dawn Mattoon, E Kevin Hrusovsky, John J Fry, Marijn E Dekkers, Mark T Roskey, and Martin D Madaus.
View insider buying and selling activity for Quanterix or view top insider-selling stocks.

QTRX stock was bought by a variety of institutional investors in the last quarter, including Frontier Capital Management Co. LLC, Clearbridge Investments LLC, Monashee Investment Management LLC, Caas Capital Management LP, Laurion Capital Management LP, First Trust Advisors LP, Lord Abbett & CO. LLC, and ExodusPoint Capital Management LP.
View insider buying and selling activity for Quanterix or or view top insider-buying stocks.

Shares of QTRX can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

One share of QTRX stock can currently be purchased for approximately $78.68.

Quanterix has a market capitalization of $2.83 billion and generates $56.73 million in revenue each year. The company earns $-40,800,000.00 in net income (profit) each year or ($1.63) on an earnings per share basis.

Quanterix employs 248 workers across the globe.

The official website for Quanterix is www.quanterix.com.

Quanterix is headquartered at 900 MIDDLESEX TURNPIKE, BILLERICA MA, 01821.

Quanterix's mailing address is 900 MIDDLESEX TURNPIKE, BILLERICA MA, 01821. The company can be reached via phone at 617-301-9400 or via email at [email protected]